Annexin 1: The new face of an old molecule

FASEB Journal

Volumn 21, Issue 4, 2007, Pages 968-975

  Lim, Lina H K ^a   Pervaiz, Shazib ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Apoptosis; Cancer; Glucocorticoids; Inflammation

Indexed keywords

CALCIUM BINDING PROTEIN; LIPOCORTIN 1; PHOSPHOLIPASE A2 INHIBITOR; PHOSPHOLIPID BINDING PROTEIN;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CARCINOGENESIS; CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; DRUG ACTIVITY; DRUG TARGETING; HUMAN; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANNEXIN A1; APOPTOSIS; CALCIUM; CELL PROLIFERATION; GLUCOCORTICOIDS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; PHAGOCYTOSIS; PHOSPHOLIPIDS; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 33947678705     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.06-7464rev     Document Type: Review

References (93)

1. Blackwell, G. J., Carnuccio, R., Di Rosa, M., Flower, R. J., Parente, L., and Persico, P. (1980) Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature 287, 147-149
2. Rothhut, B., Russo-Marie, F., Wood, J., DiRosa, M., and Flower, R. J. (1983) Further characterization of the glucocorticoid-induced antiphospholipase protein "renocortin". Biochem. Biophys. Res. Commun. 117, 878-884
3. Hirata, F., del Carmine, R., Nelson, C. A., Axelrod, J., Schiffmann, E., Warabi, A., De Blas, A. L., Nirenberg, M., Manganiello, V., Vaughan, M., Kumagai, S., Green, I., Decker, J. L., and Steinberg, A. D. (1981) Presence of autoantibody for phospholipase inhibitory protein, lipomodulin, in patients with rheumatic diseases. Proc. Natl. Acad. Sci. U. S. A. 78, 3190-3194
4. Raynal, P., and Pollard, H. B. (1994) Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim. Biophys. Acta. 1197, 63-93
5. Christmas, P., Callaway, J., Fallon, J., Jones, J., and Haigler, H. T. (1991) Selective secretion of annexin 1, a protein without a signal sequence, by the human prostate gland. J. Biol. Chem. 266, 2499-2507
6. Perretti, M., and Flower, R. J. (1996) Measurement of lipocortin 1 levels in murine peripheral blood leukocytes by flow cytometry: modulation by glucocorticoids and inflammation. Br. J. Pharmacol. 118, 605-610
7. Perretti, M., Croxtall, J. D., Wheller, S. K., Goulding, N. J., Hannon, R., and Flower, R. J. (1996) Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration. Nat. Med. 2, 1259-1262
8. Lim, L. H., Solito, E., Russo-Marie, F., Flower, R. J., and Perretti, M. (1998) Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1. Proc. Natl. Acad. Sci. U. S. A. 95, 14535-14539
9. Rescher, U., Danielczyk, A., Markoff, A., and Gerke, V. (2002) Functional activation of the formyl peptide receptor by a new endogenous ligand in human lung A549 cells. J. Immunol. 169, 1500-1504
10. Gavins, F. N., Kamal, A. M., D'Amico, M., Oliani, S. M., and Perretti, M. (2005) Formyl-peptide receptor is not involved in the protection afforded by annexin 1 in murine acute myocardial infarct. FASEB J. 19, 100-102
11. Gavins, F. N., Yona, S., Kamal, A. M., Flower, R. J., and Perretti, M. (2003) Leukocyte antiadhesive actions of annexin 1: ALXR-and FPR-related anti-inflammatory mechanisms. Blood 101, 4140-4147
12. Cirino, G., Peers, S. H., Flower, R. J., Browning, J. L., and Pepinsky, R. B. (1989) Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test. Proc. Natl. Acad. Sci. U. S. A. 86, 3428-3432
13. Cirino, G., Cicala, C., Sorrentino, L., Ciliberto, G., Arpaia, G., Perretti, M., and Flower, R. J. (1993) Anti-inflammatory actions of an N-terminal peptide from human lipocortin 1. Br. J. Pharmacol. 108, 573-574
14. Perretti, M., Ahluwalia, A., Harris, J. G., Goulding, N. J., and Flower, R. J. (1993) Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse. A qualitative comparison with an anti-CD11b monoclonal antibody. J. Immunol. 151, 4306-4314
15. Perretti, M., and Flower, R. J. (1994) Cytokines, glucocorticoids and lipocortins in the control of neutrophil migration. Pharmacol. Res. 30, 53-59
16. Teixeira, M. M., Das, A. M., Miotla, J. M., Perretti, M., and Hellewell, P. G. (1998) The role of lipocortin-1 in the inhibitory action of dexamethasone on eosinophil trafficking in cutaneous inflammatory reactions in the mouse. Br. J. Pharmacol. 123, 538-544
17. Das, A. M., Flower, R. J., Hellewell, P. G., Teixeira, M. M., and Perretti, M. (1997) A novel murine model of allergic inflammation to study the effect of dexamethasone on eosinophil recruitment. Br. J. Pharmacol. 121, 97-104
18. Errasfa, M., and Russo-Marie, F. (1989) A purified lipocortin shares the anti-inflammatory effect of glucocorticosteroids in vivo in mice. Br. J. Pharmacol. 97, 1051-1058
19. Bastian, B. C., Sellert, C., Seekamp, A., Romisch, J., Paques, E. P., and Brocker, E. B. (1993) Inhibition of human skin phospholipase A2 by "lipocortins" is an indirect effect of substrate/lipocortin interaction. J. Invest. Dermatol. 101, 359-363
20. Mukherjee, A. B., Miele, L., and Pattabiraman, N. (1994) Phospholipase A2 enzymes: regulation and physiological role. Biochem. Pharmacol. 48, 1-10
21. Chang, J., Musser, J. H., and McGregor, H. (1987) Phospholipase A2: function and pharmacological regulation. Biochem. Pharmacol. 36, 2429-2436
22. Kim, K. M., Kim, D. K., Park, Y. M., Kim, C. K., and Na, D. S. (1994) Annexin-I inhibits phospholipase A2 by specific interaction, not by substrate depletion. FEBS Lett. 343, 251-255
23. Croxtall, J. D., Choudhury, Q., Tokumoto, H., and Flower, R. J. (1995) Lipocortin-1 and the control of arachidonic acid release in cell signalling. Glucocorticoids (changed from glucorticoids) inhibit G protein-dependent activation of cPLA2 activity. Biochem. Pharmacol. 50, 465-474
24. De Coupade, C., Gillet, R., Bennoun, M., Briand, P., Russo-Marie, F., and Solito, E. (2000) Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin III SV40 T large antigen transgenic mice. Hepatology 31, 371-380
25. Hannon, R., Croxtall, J. D., Getting, S. J., Roviezzo, F., Yona, S., Paul-Clark, M. J., Gavins, F. N., Perretti, M., Morris, J. F., Buckingham, J. C., and Flower, R. J. (2003) Aberrant inflammation and resistance to glucocorticoids in annexin 1-/- mouse. FASEB J. 17, 253-255
26. McLeod, J. D., Goodall, A., Jelic, P., and Bolton, C. (1995) Changes in the cellular distribution of lipocortin-1 (Annexin-1) in C6 glioma cells after exposure to dexamethasone. Biochem. Pharmacol. 50, 1103-1107
27. Peers, S. H., Smillie, F., Elderfield, A. J., and Flower, R. J. (1993) Glucocorticoid-and non-glucocorticoid induction of lipocortins (annexins) 1 and 2 in rat peritoneal leucocytes in vivo. Br. J. Pharmacol. 108, 66-72
28. Solito, E., Nuti, S., and Parente, L. (1994) Dexamethasone-induced translocation of lipocortin (annexin) 1 to the cell membrane of U-937 cells. Br. J. Pharmacol. 112, 347-348
29. Perretti, M., Ahluwalia, A., Harris, J. G., Harris, H. J., Wheller, S. K., and Flower, R. J. (1996) Acute inflammatory response in the mouse: exacerbation by immunoneutralization of lipocortin 1. Br. J. Pharmacol. 117, 1145-1154
30. Philip, J. G., Flower, R. J., and Buckingham, J. C. (1997) Glucocorticoids modulate the cellular disposition of lipocortin 1 in the rat brain in vivo and in vitro. Neuroreport 8, 1871-1876
31. Solito, E., Mulla, A., Morris, J. F., Christian, H. C., Flower, R. J., and Buckingham, J. C. (2003) Dexamethasone induces rapid serine-phosphorylation and membrane translocation of annexin 1 in a human folliculostellate cell line via a novel nongenomic mechanism involving the glucocorticoid receptor, protein kinase C, phosphatidylinositol 3-kinase, and mitogen-activated protein kinase. Endocrinology 144, 1164-1174
32. Strijbos, P. J., Horan, M. A., Carey, F., and Rothwell, N. J. (1993) Impaired febrile responses of aging mice are mediated by endogenous lipocortin-1 (annexin-1). Am. J. Physiol. 265, E289-297
33. Yang, Y. H., Hutchinson, P., Leech, M., and Morand, E. F. (1997) Exacerbation of adjuvant arthritis by adrenalectomy is associated with reduced leukocyte lipocortin 1. J. Rheumatol. 24, 1758-1764
34. Taylor, A. D., Cowell, A. M., Flower, J., and Buckingham, J. C. (1993) Lipocortin 1 mediates an early inhibitory action of glucocorticoids on the secretion of ACTH by the rat anterior pituitary gland in vitro. Neuroendocrinology 58, 430-439
35. Loxley, H. D., Cowell, A. M., Flower, R. J., and Buckingham, J. C. (1993) Effects of lipocortin 1 and dexamethasone on the secretion of corticotrophin-releasing factors in the rat: in vitro and in vivo studies. J. Neuroendocrinol. 5, 51-61
36. Morand, E. F., Jefferiss, C. M., Dixey, J., Mitra, D., and Goulding, N. J. (1994) Impaired glucocorticoid induction of mononuclear leukocyte lipocortin-1 in rheumatoid arthritis. Arthritis Rheum. 37, 207-211
37. Goulding, N. J., Jefferiss, C. M., Pan, L., Rigby, W. F., and Guyre, P. M. (1992) Specific binding of lipocortin-1 (annexin I) to monocytes and neutrophils is decreased in rheumatoid arthritis. Arthritis Rheum. 35, 1395-1397
38. Yang, Y., Leech, M., Hutchinson, P., Holdsworth, S. R., and Morand, E. F. (1997) Antiinflammatory effect of lipocortin 1 in experimental arthritis. Inflammation 21, 583-596
39. Cuzzocrea, S., Tailor, A., Zingarelli, B., Salzman, A. L., Flower, R. J., Szabo, C., and Perretti, M. (1997) Lipocortin 1 protects against splanchnic artery occlusion and reperfusion injury by affecting neutrophil migration. J. Immunol. 159, 5089-5097
40. Davidson, J., Flower, R. J., Milton, A. S., Peers, S. H., and Rotondo, D. (1991) Antipyretic actions of human recombinant lipocortin-1. Br. J. Pharmacol. 102, 7-9
41. Ferreira, S. H., Cunha, F. Q., Lorenzetti, B. B., Michelin, M. A., Perretti, M., Flower, R. J., and Poole, S. (1997) Role of lipocortin-1 in the anti-hyperalgesic actions of dexamethasone. Br. J. Pharmacol. 121, 883-888
42. Smith, S. F., Tetley, T. D., Guz, A., and Flower, R. J. (1990) Detection of lipocortin 1 in human lung lavage fluid: lipocortin degradation as a possible proteolytic mechanism in the control of inflammatory mediators and inflammation. Environ. Health. Perspect. 85, 135-144
43. Smith, S. F., Tetley, T. D., Datta, A. K., Smith, T., Guz, A., and Flower, R. J. (1995) Lipocortin-1 distribution in bronchoalveolar lavage from healthy human lung: effect of prednisolone. J. Appl. Physiol. 79, 121-128
44. Van Hal, P. T., Overbeek, S. E., Hoogsteden, H. C., Zijlstra, F. J., Murphy, K., Oosterhoff, Y., Postma, D. S., Guz, A., and Smith, S. F. (1996) Eicosanoids and lipocortin-1 in BAL fluid in asthma: effects of smoking and inhaled glucocorticoids. J. Appl. Physiol. 81, 548-555
45. Perretti, M., Wheller, S. K., Choudhury, Q., Croxtall, J. D., and Flower, R. J. (1995) Selective inhibition of neutrophil function by a peptide derived from lipocortin 1 N-terminus. Biochem. Pharmacol. 50, 1037-1042
46. Getting, S. J., Flower, R. J., and Perretti, M. (1997) Inhibition of neutrophil and monocyte recruitment by endogenous and exogenous lipocortin 1. Br. J. Pharmacol. 120, 1075-1082
47. Harris, J. G., Flower, R. J., and Perretti, M. (1995) Alteration of neutrophil trafficking by a lipocortin 1 N-terminus peptide. Eur. J. Pharmacol. 279, 149-157
48. Oliani, S. M., Paul-Clark, M. J., Christian, H. C., Flower, R. J., and Perretti, M. (2001) Neutrophil interaction with inflamed postcapillary venule endothelium alters annexin 1 expression. Am. J. Pathol. 158, 603-615
49. Croxtall, J., Flower, R., and Perretti, M. (1993) The role of lipocortin 1 in the regulation of A549 cell proliferation and leukocyte migration. J. Lipid. Mediat. 6, 295-302
50. Alldridge, L. C., Harris, H. J., Plevin, R., Hannon, R., and Bryant, C. E. (1999) The annexin protein lipocortin 1 regulates the MAPK/ERK pathway. J. Biol. Chem. 274, 37620-37628
51. De, B. K., Misono, K. S., Lukas, T. J., Mroczkowski, B., and Cohen, S. (1986) A calcium-dependent 35-kilodalton substrate for epidermal growth factor receptor/kinase isolated from normal tissue. J. Biol. Chem. 261, 13784-13792
52. Croxtall, J. D., Waheed, S., Choudhury, Q., Anand, R., and Flower, R. J. (1993) N-terminal peptide fragments of lipocortin-1 inhibit A549 cell growth and block EGF-induced stimulation of proliferation. Int. J. Cancer. 54, 153-158
53. Alldridge, L. C., and Bryant, C. E. (2003) Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal. Exp. Cell Res. 290, 93-107
54. Skouteris, G. G., and Schroder, C. H. (1996) The hepatocyte growth factor receptor kinase-mediated phosphorylation of lipocortin-1 transduces the proliferating signal of the hepatocyte growth factor. J. Biol. Chem. 271, 27266-27273
55. Varticovski, L., Chahwala, S. B., Whitman, M., Cantley, L., Schindler, D., Chow, E. P., Sinclair, L. K., and Pepinsky, R. B. (1988) Location of sites in human lipocortin I that are phosphorylated by protein tyrosine kinases and protein kinases A and C. Biochemistry 27, 3682-3690
56. Dorovkov, M. V., and Ryazanov, A. G. (2004) Phosphorylation of annexin I by TRPM7 channel-kinase. J. Biol. Chem. 279, 50643-50646
57. Hsiang, C. H., Tunoda, T., Whang, Y. E., Tyson, D. R., and Ornstein, D. K. (2006) The impact of altered annexin I protein levels on apoptosis and signal transduction pathways in prostate cancer cells. Prostate 66, 1413-1424
58. McKanna, J. A. (1995) Lipocortin 1 in apoptosis: mammary regression. Anat. Rec. 242, 1-10
59. Sakamoto, T., Repasky, W. T., Uchida, K., Hirata, A., and Hirata, F. (1996) Modulation of cell death pathways to apoptosis and necrosis of H2O2-treated rat thymocytes by lipocortin I. Biochem. Biophys. Res. Commun. 220, 643-647
60. Canaider, S., Solito, E., de Coupade, C., Flower, R. J., Russo-Marie, F., Goulding, N. J., and Perretti, M. (2000) Increased apoptosis in U937 cells over-expressing lipocortin 1 (annexin I). Life Sci. 66, PL265-270
61. Solito, E., de Coupade, C., Canaider, S., Goulding, N. J., and Perretti, M. (2001) Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation. Br. J. Pharmacol. 133, 217-228
62. Solito, E., Kamal, A., Russo-Marie, F., Buckingham, J. C., Marullo, S., and Perretti, M. (2003) A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils. FASEB J. 17, 1544-1546
63. Ishido, M. (2005) Overexpression of Bcl-2 inhibits nuclear localization of annexin I during tumor necrosis factor-alpha-mediated apoptosis in porcine renal LLC-PK1 cells. Regul. Pept. 124, 45-51
64. Petrella, A., Festa, M., Ercolino, S. F., Zerilli, M., Stassi, G., Solito, E., and Parente, L. (2005) Induction of annexin-1 during TRAIL-induced apoptosis in thyroid carcinoma cells. Cell Death. Differ. 12, 1358-1360
65. Wu, Y. L., Jiang, X. R., Lillington, D. M., Newland, A. C., and Kelsey, S. M. (2000) Upregulation of lipocortin 1 inhibits tumour necrosis factor-induced apoptosis in human leukaemic cells: a possible mechanism of resistance to immune surveillance. Br. J. Haematol. 111, 807-816
66. Carollo, M., Parente, L., and D'Alessandro, N. (1998) Dexamethasone-induced cytotoxic activity and drug resistance effects in androgen-independent prostate tumor PC-3 cells are mediated by lipocortin 1. Oncol. Res. 10, 245-254
67. Arur, S., Uche, U. E., Rezaul, K., Fong, M., Scranton, V., Cowan, A. E., Mohler, W., and Han, D. K. (2003) Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev. Cell. 4, 587-598
68. Bitto, E., Li, M., Tikhonov, A. M., Schlossman, M. L., and Cho, W. (2000) Mechanism of annexin I-mediated membrane aggregation. Biochemistry 39, 13469-13477
69. Rosengarth, A., Gerke, V., and Luecke, H. (2001) X-ray structure of full-length annexin 1 and implications for membrane aggregation. J. Mol. Biol. 306, 489-498
70. Lambert, O., Gerke, V., Bader, M. F., Porte, F., and Brisson, A. (1997) Structural analysis of junctions formed between lipid membranes and several annexins by cryo-electron microscopy. J. Mol. Biol. 272, 42-55
71. Gerke, V., and Moss, S. E. (2002) Annexins: from structure to function. Physiol. Rev. 82, 331-371
72. Mailliard, W. S., Haigler, H. T., and Schlaepfer, D. D. (1996) Calcium-dependent binding of S100C to the N-terminal domain of annexin I. J. Biol. Chem. 271, 719-725
73. Seemann, J., Weber, K., and Gerke, V. (1996) Structural requirements for annexin I-S100C complex-formation. Biochem. J. 319 (Pt 1), 123-129
74. Fan, X., Krahling, S., Smith, D., Williamson, P., and Schlegel, R. A. (2004) Macrophage surface expression of annexins I and II in the phagocytosis of apoptotic lymphocytes. Mol. Biol. Cell 15, 2863-2872
75. Xia, S. H., Hu, L. P., Hu, H., Ying, W. T., Xu, X., Cai, Y., Han, Y. L., Chen, B. S., Wei, F., Qian, X. H., Cai, Y. Y., Shen, Y., Wu, M., and Wang, M. R. (2002) Three isoforms of annexin I are preferentially expressed in normal esophageal epithelia but down-regulated in esophageal squamous cell carcinomas. Oncogene 21, 6641-6648
76. Xin, W., Rhodes, D. R., Ingold, C., Chinnaiyan, A. M., and Rubin, M. A. (2003) Dysregulation of the annexin family protein family is associated with prostate cancer progression. Am. J. Pathol. 162, 255-261
77. Garcia Pedrero, J. M., Fernandez, M. P., Morgan, R. O., Herrero Zapatero, A., Gonzalez, M. V., Suarez Nieto, C., and Rodrigo, J. P. (2004) Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. Am. J. Pathol. 164, 73-79
78. Ahn, S. H., Sawada, H., Ro, J. Y., and Nicolson, G. L. (1997) Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues. Clin. Exp. Metastasis. 15, 151-156
79. Shen, D., Nooraie, F., Elshimali, Y., Lonsberry, V., He, J., Bose, S., Chia, D., Seligson, D., Chang, H. R., and Goodglick, L. (2006) Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum. Pathol. 37, 1583-1591
80. Paweletz, C. P., Ornstein, D. K., Roth, M. J., Bichsel, V. E., Gillespie, J. W., Calvert, V. S., Vocke, C. D., Hewitt, S. M., Duray, P. H., Herring, J., et al. (2000) Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res. 60, 6293-6297
81. Hu, N., Flaig, M. J., Su, H., Shou, J. Z., Roth, M. J., Li, W. J., Wang, C., Goldstein, A. M., Li, G., Emmert-Buck, M. R., and Taylor, P. R. (2004) Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma. Clin. Cancer Res. 10, 6013-6022
82. Zhi, H., Zhang, J., Hu, G., Lu, J., Wang, X., Zhou, C., Wu, M., and Liu, Z. (2003) The deregulation of arachidonic acid metabolism-related genes in human esophageal squamous cell carcinoma. Int. J. Cancer. 106, 327-333
83. Kang, J. S., Calvo, B. F., Maygarden, S. J., Caskey, L. S., Mohler, J. L., and Ornstein, D. K. (2002) Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Clin. Cancer Res. 8, 117-123
84. Smitherman, A. B., Mohler, J. L., Maygarden, S. J., and Ornstein, D. K. (2004) Expression of annexin I, II and VII proteins in androgen stimulated and recurrent prostate cancer. J. Urol. 171, 916-920
85. Patton, K. T., Chen, H. M., Joseph, L., and Yang, X. J. (2005) Decreased annexin I expression in prostatic adenocarcinoma and in high-grade prostatic intraepithelial neoplasia. Histopathology 47, 597-601
86. Rodrigo, J. P., Garcia-Pedrero, J. M., Fernandez, M. P., Morgan, R. O., Suarez, C., and Herrero, A. (2005) Annexin A1 expression in nasopharyngeal carcinoma correlates with squamous differentiation. Am. J. Rhinol. 19, 483-487
87. Vishwanatha, J. K., Salazar, E., and Gopalakrishnan, V. K. (2004) Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines. BMC Cancer. 4, 8
88. Falini, B., Tiacci, E., Liso, A., Basso, K., Sabattini, E., Pacini, R., Foa, R., Pulsoni, A., Dalla Favera, R., and Pileri, S. (2004) Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). Lancet 363, 1869-1870
89. Mulla, A., Christian, H. C., Solito, E., Mendoza, N., Morris, J. F., and Buckingham, J. C. (2004) Expression, subcellular localization and phosphorylation status of annexins 1 and 5 in human pituitary adenomas and a growth hormone-secreting carcinoma. Clin. Endocrinol. (Oxf). 60, 107-119
90. Shen, D., Chang, H. R., Chen, Z., He, J., Lonsberry, V., Elshimali, Y., Chia, D., Seligson, D., Goodglick, L., Nelson, S. F., and Gornbein, J. A. (2005) Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses. Biochem. Biophys. Res. Commun. 326, 218-227
91. Bai, X. F., Ni, X. G., Zhao, P., Liu, S. M., Wang, H. X., Guo, B., Zhou, L. P., Liu, F., Zhang, J. S., Wang, K., Xie, Y. Q., Shao, Y. F., and Zhao, X. H. (2004) Overexpression of annexin 1 in pancreatic cancer and its clinical significance. World J. Gastroenterol. 10, 1466-1470
92. Sheng, K. H., Yao, Y. C., Chuang, S. S., Wu, H., and Wu, T. F. (2006) Search for the tumor-related proteins of transition cell carcinoma in Taiwan by proteomic analysis. Proteomics 6, 1058-1065
93. Xiao, G. S., Jin, Y. S., Lu, Q. Y., Zhang, Z. F., Belldegrun, A., Figlin, R., Pantuck, A., Yen, Y., Li, F., and Rao, J. (2007) Annexin-I as a potential target for green tea extract induced actin remodeling. Int. J. Cancer 120, 111-120